Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07051278 · ClinicalTrials.gov registry record · NA
ABL90 FLEX PLUS Method Comparison Neonatal Capillary
A NA study of Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects, sponsored by Radiometer Medical ApS.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 3
- Study locations
NCT07051278: Completed NA study of Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects, sponsored by Radiometer Medical ApS.
NCT07051278 is a NA study of Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects that has completed, run by Radiometer Medical ApS. The registered enrollment target is 129 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07051278, a NA study of Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects, has completed, sponsored by Radiometer Medical ApS.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study is intended to validate performance claims for method comparison for ABL90 FLEX PLUS in heparinized neonatal capillary whole blood for ctBil and FHbF in a POC setting
Primary Outcome
Bias between device under investigation and comparative device at medical decision level across sites; (unit is mg/dL)
Conditions Studied
Interventions
- DEVICE Method Comparison
Study Locations (3)
New York
- Albert Einstein College of Medicine - The Bronx
North Carolina
- Duke University - Durham
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2023-11-10 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What the finished NCT07051278 record still lists
NCT07051278 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects appearing as the primary indexed condition, and to 1 intervention - of which Method Comparison is the first listed.
NCT07051278 reports a single indexed study location in New York, North Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT07051278 about?
NCT07051278 is a clinical study titled "ABL90 FLEX PLUS Method Comparison Neonatal Capillary". The study is intended to validate performance claims for method comparison for ABL90 FLEX PLUS in heparinized neonatal capillary whole blood for ctBil and FHbF in a POC setting
What is the current status of trial NCT07051278?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2023-11-10. Estimated completion is 2025-01-31.
What conditions does trial NCT07051278 study?
This clinical trial studies the following conditions: Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects.
What interventions are being tested in trial NCT07051278?
The interventions under investigation include: Method Comparison (DEVICE).
Who is sponsoring clinical trial NCT07051278?
This trial is sponsored by Radiometer Medical ApS, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07051278 being conducted?
This trial has 3 study locations across New York, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07051278's enrollment target sits among peer trials
129 744th of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI